The Impact of FDA Ingredient Listing Delay to Vape Manufacturers

By November 9, 2017 December 26th, 2017 News

Today we want to discuss The Impact of FDA Ingredient Listing Delay to Vape Manufacturers.
All content source from vaping360 or internet.
Any questions, please contact Wellon, we will handle it with 24H.
The Impact of FDA Ingredient Listing Delay to Vape Manufacturers

FDA Extends Ingredient Listing Submissions Deadline

FDA is extending the compliance deadline to submit ingredient listings for deemed tobacco products by six months due to technical issues users encountered with eSubmitter. FDA is extending this compliance deadline to provide manufacturers with additional time to submit the ingredient listing information required under Section 905 of the FD&C Act.

FDA does not intend to enforce the submission requirement for deemed tobacco products that were on the market as of Aug. 8, 2016, until May 8, 2018 (or November 8, 2018 for small-scale manufacturers). These extended dates now apply to all manufacturers and importers, including those in an area impacted by recent natural disasters. Deemed tobacco products entering the market after Aug. 8, 2016, must submit the ingredient information at least 90 days before the product is introduced to interstate commerce. FDA encourages manufacturers to start the process as early as possible.

For more information, please contact the FDA at or 1.877.287.1371.

How Should Vape Manufacturer Handle FDA Ingredient Listing Delay?

Will the FDA ever come up with real standards for vape manufacturers?
We don’t know FDA next plan to small vape manufacturers.
Listings for small-scale manufacturers — those with fewer than 150 employees or sales under $5 million per year — were due next May 8. Those smaller companies will now have a year to complete this required action, until Nov. 8, 2018.

Source: vaping360